TAAT LTD has recently launched its official website, initiated social media campaigns on Facebook, Instagram, and Twitter, and released its corporate introduction video in which its management provides an overview of the Company, Taat Beyond Tobacco™ cigarettes, and their plans for entering the US $814 billion global tobacco industry. This initial digital rollout is in preparation for the planned launch of Taat Beyond Tobacco™ cigarettes which is scheduled to occur in Q4 2020.
LAS VEGAS and VANCOUVER, British Columbia, July 02, 2020 (GLOBE NEWSWIRE) -- Taat Lifestyle & Wellness Ltd. (CSE:TAAT)(the “Company” or “TAAT LTD”) is pleased to announce it has recently completed its initial digital media rollout, to include the launch of its official website and social media channels, as well as the release of its corporate introduction video. The Company is taking aim at the US $814 billion global tobacco marketplace with the planned launch of its flagship product Taat Beyond Tobacco™ cigarettes, a better-for-you smoking alternative which emulates the experience of smoking a traditional tobacco cigarette. In preparation for the planned Q4 2020 launch of Taat Beyond Tobacco™ cigarettes, the Company has been establishing its online and digital presence to avail information about TAAT LTD and Taat Beyond Tobacco™ cigarettes to the general public. In late June, the Company launched its homepage, began social media campaigns on each of Facebook, Twitter, and Instagram, and published an introduction video in which the Company’s management narrates the Company’s story and its plans for positioning itself in the tobacco industry.
TAAT LTD Official Website
To offer a centralized, comprehensive information resource for prospective investors, Taat Beyond Tobacco™ cigarette users, vendors and distribution partners, and the general public alike, the Company has designed its official website to provide an abundance of insights about the Company, its products, and the market it intends to penetrate. A dedicated investor section allows users to view the Company’s latest presentation deck and press releases. Further, an e-commerce function powered by Shopify has been integrated into the website to allow for immediate activation for direct-to-consumer sales upon the official release of Taat Beyond Tobacco™ cigarettes.
The TAAT LTD official website can be accessed at the following link: http://taatusa.com.
Social Media Channels
In the interest of providing the latest updates about TAAT LTD and Taat Beyond Tobacco™ cigarettes, the Company has commenced campaigns on the Facebook, Instagram, and Twitter social media platforms. Interested parties may view and follow the Company’s social media channels by searching for the respective account names listed below.
Corporate Introduction Video
In June 2020, the Company produced a corporate introduction video in which its management discusses TAAT LTD, Taat Beyond Tobacco™ cigarettes, and the anticipated market position of the product upon its launch that is planned to occur in Q4 2020. Throughout the video, several live-action visuals of Taat Beyond Tobacco™ cigarettes and their production are shown, reflecting the Company’s cumulative research and development progress to date. The corporate introduction video has a duration of 2 minutes and 21 seconds, and can be viewed at the following link: https://youtu.be/1nFPGovcY_Q or click on link below.
A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/be219332-34b9-4cc3-a995-ec0a5c710b94
As announced in its June 29, 2020 press release, the Company recently completed its initial phase of retail market testing of Taat Beyond Tobacco™ cigarettes which yielded overwhelmingly positive responses from users who obtained the product from more than 50 retail stores in Nevada and California. The subsequent phase is expected to consist of an intensive series of focus groups, the insights from which will be used to optimize the strategy for the official launch of Taat Beyond Tobacco™ cigarettes, which remains on schedule to occur in Q4 2020.
TAAT LTD Founder Joe Deighan commented, “It is very exciting for us to be in a stage in which Taat Beyond Tobacco™ cigarettes are so close to launching that we can now release public-facing media about the product and the Company. The demand from tobacco smokers for a better-for-you alternative to traditional cigarettes is persisting, and we have worked very hard to engineer a product in the ‘stick’ format which emulates the experience of smoking a traditional cigarette while potentially helping users to transition off of the addictive product. We have made significant strides in 2020 and I was delighted to have the opportunity to tell the world about them in our corporate video. Our team has created a presentable and informative website for TAAT LTD, in addition to building a dynamic and engagement-driven social media strategy to start building buzz in anticipation of our planned Q4 2020 launch.”
About Taat Lifestyle & Wellness Ltd.
Taat Herb Co., the flagship brand of Taat Lifestyle & Wellness Ltd. (CSE:TAAT), is an early-stage life sciences company based in Las Vegas, Nevada innovating nicotine-free and tobacco-free alternatives to traditional cigarettes. With a unique proprietary blend of all-natural ingredients and meticulous engineering of the user experience, Taat Beyond Tobacco™ cigarettes are designed to emulate every aspect of legacy tobacco products with no significant difference to the user. Taat Beyond Tobacco™ cigarettes provide benefits that include mitigation of tobacco withdrawals, and reduction of tobacco dependency. With an expert-led go-to-market strategy, the Company's objective is to position itself in the US $814 billion (2018) global tobacco industry to capitalize on the growing worldwide demand for better-for-you alternatives to traditional cigarettes.
For more information, please visit http://taatusa.com.
Statement Regarding Effects of CBD on Smoking Cessation
The Beckley/Exeter research program (University of Exeter) carried out a pilot study that found after several weeks following cannabidiol ("CBD") treatment, CBD helped tobacco smokers to reduce the amount of cigarettes smoked by as much as 40%. A follow-on study is planned, which will include a brain imaging component to examine the brain activity patterns underlying the probable therapeutic effects of CBD.
Forward Looking Statements
This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur, or be achieved. Forward-looking information in this news release includes statements regarding the potential launch of Taat hemp cigarettes. The forward-looking information reflects management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed timeframes or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the tobacco and CBD markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.
The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual’s health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease.
This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by the Company with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with the Company is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.